Tag Archives: Early Stage Biotech VC

Atlas Cranks It Up To Eleven: Fund XI
June 29, 2017

Today we announced the closing of Atlas Venture Fund XI, a $350M investment vehicle focused exclusively on early stage biotech investing. Since launching our fundraising process in April, we’ve received a truly humbling level of support and interest in our

1 Comment